Denali Therapeutics, Inc. (DNLI)
20.93
+2.33
(+12.53%)
USD |
NASDAQ |
Jan 22, 16:00
20.93
0.00 (0.00%)
After-Hours: 06:28
Denali Therapeutics Research and Development Expense (TTM): 420.66M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Enovis Corp. | 112.92M |
| Masimo Corp. | 172.00M |
| Protalix Biotherapeutics, Inc. | 18.06M |
| Twist Bioscience Corp. | 80.28M |
| AIM ImmunoTech, Inc. | 3.826M |